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POPULATION SAMPLE
The six participating regional cancer centres were selected with a view to giving a representative picture of the French population as a whole (south: Marseille, Toulouse; north: Lille; west: Nantes; centre: Paris/St Cloud, Clermont-Ferrand) and covered a total population of more than 4 million inhabitants. The main criterion used for inclusion in the study was the presence of breast cancer running in the family, either in the patient or in at least one first degree relative when she was not affected herself. All the healthy cases included had at least one first degree relative with breast cancer. All the affected ones had a first degree relative with cancer and when the consultand herself was not affected she had at least one first degree relative who was. The consultands were female adult cancer patients and healthy patients who were asked to participate when attending the cancer genetic clinics for the first time between January 1994 and January 1995.
CONSULTANDS' QUESTIONNAIRES
The consultands were mailed a standardised questionnaire (with a stamped envelope) during the week after the consultation. If no answer was received within two weeks of the first letter, a reminder was sent, followed after a second period of two weeks by a complete package (letter, questionnaire, and stamped envelope). The questions asked about the attitudes towards breast cancer predictive testing are given in the appendix.
Both open ended and closed questions were used to enquire about the transmission of information to relatives about the family cancer risk, how this information was received, 72ulian-Reynier et al 7 3.4
The anxiety in the whole family would be (n=197) 
ATTITUDES TOWARDS TRANSMISSION OF INFORMATION TO RELATIVES
The consultands' attitudes towards informing their relatives of the existence of genetic testing for breast cancer were very positive, since 89.7% of them answered that they would inform the family members at risk about the availability of predictive testing (table 2) . During the consultation, the oncogeneticist told 68.9% of the consultands (n=144) that it might be worthwhile contacting their relatives because of the cancer risk. When asked after the consultation whether the oncogeneticist had asked them to contact their relatives, 77% (n=161) of the women answered that this was the case, although 28 of them had not actually been asked by the oncogeneticist to do so; 11 women did not acknowledge the fact that they Huntington's disease is often used as a model for cancer predictive testing, but the main difference from breast cancer predictive testing is that there is still no hope of prevention or cure for Huntington's disease. Since the hope of preventing breast cancer is the rationale underlying the existence of cancer genetic clinics, it seems impossible for physicians not to act in some way. In the case of Huntington's disease, the patients' uptake of predictive testing3"32 was far lower than expected on the basis of the a priori attitudes towards testing. [33] [34] [35] In the field of hereditary breast cancer, preliminary results indicate that the uptake of testing is close to 50%...... The way in which information about the efficacy of preventive strategies is presented in the future will be one of the keys to ensuring that cancer genetic testing becomes widely accepted.
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